Mode
Text Size
Log in / Sign up
Phase 4 N=12 Randomized Triple-blind Treatment

The Effect of Protein on Calcium Absorption and Gastric Acid Production

Osteoporosis

Enrolled (actual)
12
Serious AEs
0.0%
Results posted
Jan 2013
Primary outcome: Primary: Percent Change in Intestinal Calcium Absorption — 34.2; 31.5 percentage of calcium absorption

Study Design & Population

Study type
Interventional
Phase
Phase 4
Interventions
esomeprazole (Drug); Placebo (Drug)
Age
Adult · 18+ yrs
Sex
All
Sponsor
Yale University
Primary completion
May 2008

Outcome Measures

OutcomeResultp-value
PRIMARY
Percent Change in Intestinal Calcium Absorption
34.2; 31.5
SECONDARY
Gastric pH
5.38; 2.70

Summary

We have established that dietary protein is an important regulator of intestinal calcium absorption in humans. However, we do not understand the mechanism by which dietary protein is affecting calcium absorption. Therefore, the purpose of this research is to evaluate whether dietary protein-induced changes in gastric acid secretion explain the observed changes in intestinal calcium absorption.

Eligibility Criteria

Inclusion Criteria

  • Healthy men and women age 18-45 years
  • Caucasian or Asian descent due to increased risk of Osteoporosis

Exclusion Criteria

  • gastrointestinal diseases
  • osteoporosis
  • diabetes
  • hypertension
  • liver disease
  • thyroid disorders
  • kidney disease
  • kidney stones
  • cancer
  • heart disease
  • eating disorders
  • obesity
  • hypogonadism
  • amenorrhea
  • oligomenorrhea
  • abnormal serum FSH or estradiol levels
  • birth control medication or other hormone-altering medications
  • pregnancy
  • Lifestyle factors such as:
  • smoking
  • excessive exercise (although moderate exercise is allowed)
  • prescription medications known to influence vitamin D or calcium metabolism or gastric acid
  • excessive body weight change during the past 6 months
  • food allergies
  • unusual eating habits or medically prescribed diets
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00719160). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search